BerandaQL1A • FRA
add
Quidelortho Corp
Tutup sebelumnya
€24,20
Rentang hari
€24,00 - €24,60
Rentang tahun
€21,20 - €45,40
Kapitalisasi pasar
1,90 M USD
Volume Rata-Rata
22,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Pendapatan | 692,80 jt | -2,56% |
Biaya operasional | 294,60 jt | -8,96% |
Laba bersih | -12,70 jt | 99,26% |
Margin laba bersih | -1,83 | 99,24% |
Penghasilan per saham | 0,74 | 68,18% |
EBITDA | 155,80 jt | 26,26% |
Tarif pajak efektif | -44,32% | — |
Neraca
Total aset
Total liabilitas
(USD) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 128,00 jt | 62,44% |
Total aset | 6,46 M | -3,61% |
Total liabilitas | 3,46 M | 2,03% |
Total ekuitas | 3,00 M | — |
Saham yang beredar | 67,63 jt | — |
Harga terhadap nilai buku | 0,55 | — |
Tingkat pengembalian aset | 1,89% | — |
Tingkat pengembalian modal | 2,14% | — |
Arus Kas
Perubahan kas bersih
(USD) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Laba bersih | -12,70 jt | 99,26% |
Kas dari operasi | 65,60 jt | 9.471,43% |
Kas dari investasi | -56,20 jt | -178,22% |
Kas dari pembiayaan | 17,60 jt | 195,14% |
Perubahan kas bersih | 28,70 jt | 170,86% |
Arus kas bebas | 51,40 jt | 250,18% |
Tentang
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
Didirikan
1979
Kantor pusat
Situs
Karyawan
6.600